Philogen S.p.A. announced that Pfizer Inc. (NYSE: PFE) has exercised options granted under the agreement established in December 2014 for the potential development and commercialization of multiple antibody drug conjugates (ADCs). Siena, Italy, 21st January 2016.
News & Events
Philogen S.p.A. announced that Pfizer Inc. (NYSE: PFE) has exercised options granted under the agreement
Last News & Events
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.